AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19841835 — intervention group
Group type: COMPARATOR
Intervention: Traditional physical therapy for the upper limb
Number of subjects: 36
Study 17014748 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 153
Study 17014748 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and Support Group (EAS)
Number of subjects: 153
Study 17014748 — intervention group
Group type: COMPARATOR
Intervention: Standard Medical Care (SMC)
Number of subjects: 153
Study 15307942 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole (MMI)
Number of subjects: 100
Study 15307942 — intervention group
Group type: EXPERIMENTAL
Intervention: No drug (ND)
Number of subjects: 100
Study 15307942 — intervention group
Group type: EXPERIMENTAL
Intervention: Propylthiouracil (PTU)
Number of subjects: 100
Study 11189686 — intervention group
Group type: EXPERIMENTAL
Intervention: Data management systems developed for the PLCO trial
Number of subjects: 0
Study 11189686 — intervention group
Group type: EXPERIMENTAL
Intervention: Applications for data entry, editing, trial management, reporting, telecommunications, and data sharing
Number of subjects: 0
Study 9009296 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 908-htrA and CVD 906-htrA vaccine strains at doses of 5 x 10(7) to 5 x 10(9) CFU
Number of subjects: 36
Study 9009296 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 908-htrA and CVD 906-htrA vaccine strains at doses of 5 x 10(8) to 5 x 10(9) CFU
Number of subjects: 36
Study 9009296 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 908-htrA and CVD 906-htrA vaccine strains
Number of subjects: 36
Study 9009296 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 908-htrA and CVD 906-htrA vaccine strains at higher doses
Number of subjects: 36
Study 8388286 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine suspension
Number of subjects: 60
Study 8388286 — intervention group
Group type: COMPARATOR
Intervention: Placebo suspension
Number of subjects: 60
Study 3476523 — intervention group
Group type: EXPERIMENTAL
Intervention: 2800 ppm F as SMFP
Number of subjects: 0
Study 3476523 — intervention group
Group type: COMPARATOR
Intervention: 1100 ppm F as NaF (positive control)
Number of subjects: 0
Study 3476523 — intervention group
Group type: EXPERIMENTAL
Intervention: 2800 ppm F as NaF
Number of subjects: 0
Study 31995787 — intervention group
Group type: EXPERIMENTAL
Intervention: Rugby-specific sprint interval training (SITr/s)
Number of subjects: 31
Study 31995787 — intervention group
Group type: COMPARATOR
Intervention: Running-only sprint interval training (SITr)
Number of subjects: 31
Study 28834248 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA; 75 mg)
Number of subjects: 31
Study 28834248 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBU; 1200 mg)
Number of subjects: 31
Study 28834248 — intervention group
Group type: COMPARATOR
Intervention: Weight-stack training (WS)
Number of subjects: 31
Study 28834248 — intervention group
Group type: COMPARATOR
Intervention: Flywheel ergometer training (FW)
Number of subjects: 31
Study 28834248 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBU)
Number of subjects: 31
Study 26518190 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg taken 30 min before a meal (pre-Met protocol)
Number of subjects: 23
Study 26518190 — intervention group
Group type: COMPARATOR
Intervention: Metformin 1000 mg taken with a meal (Met protocol)
Number of subjects: 23
Study 26518190 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 600 mg/kg taken 10 min before a meal (pre-Met)
Number of subjects: 23
Study 26518190 — intervention group
Group type: COMPARATOR
Intervention: Metformin 600 mg/kg taken with a meal (Met)
Number of subjects: 23
Study 26518190 — intervention group
Group type: COMPARATOR
Intervention: No medication (Control)
Number of subjects: 23
Study 26518190 — intervention group
Group type: EXPERIMENTAL
Intervention: Total GLP-1 level at t = 30 min of pre-Met protocol
Number of subjects: 23
Study 26518190 — intervention group
Group type: EXPERIMENTAL
Intervention: Total GLP-1 level at t = 0 min of pre-Met
Number of subjects: 23
Study 25552525 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke support person-directed intervention
Number of subjects: 31
Study 25552525 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed intervention
Number of subjects: 31
Study 25552525 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 31
Study 23065707 — intervention group
Group type: EXPERIMENTAL
Intervention: Neo-adjuvant radiotherapy (group 1)
Number of subjects: 3
Study 23065707 — intervention group
Group type: COMPARATOR
Intervention: Irradiated tumor tissue (group 1)
Number of subjects: 3
Study 23065707 — intervention group
Group type: COMPARATOR
Intervention: Colorectal cancer patients not undergoing neo-adjuvant radiotherapy (group 2)
Number of subjects: 3
Study 23065707 — intervention group
Group type: COMPARATOR
Intervention: Non-cancer patient group (group 3)
Number of subjects: 3
Study 20924392 — intervention group
Group type: EXPERIMENTAL
Intervention: Barley β-glucan
Number of subjects: 11
Study 20924392 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 11
Study 18250365 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary nitrate load (beetroot juice 500 mL)
Number of subjects: 0
Study 18250365 — intervention group
Group type: COMPARATOR
Intervention: Interruption of the enterosalivary conversion of nitrate to nitrite
Number of subjects: 0
Study 15167995 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrafascial abdominal hysterectomy
Number of subjects: 80
Study 15167995 — intervention group
Group type: COMPARATOR
Intervention: Extrafascial abdominal hysterectomy
Number of subjects: 80
Study 11826763 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant follicle-stimulating hormone (FSH)
Number of subjects: 0
Study 11826763 — intervention group
Group type: COMPARATOR
Intervention: Urinary follicle-stimulating hormone (FSH)
Number of subjects: 0
Study 9505770 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural bupivacaine (0.048% w/v in early labour)
Number of subjects: 2
Study 9505770 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural bupivacaine (0.140% w/v in late labour)
Number of subjects: 2
Study 9505770 — intervention group
Group type: COMPARATOR
Intervention: Comparison of MLAC in early vs late labour
Number of subjects: 2
Study 8113458 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin 0.1% cream applied twice daily for 24 weeks
Number of subjects: 100
Study 8113458 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle) applied twice daily for 24 weeks
Number of subjects: 100
Study 3291837 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levobunolol and 0.1% dipivefrin
Number of subjects: 43
Study 3291837 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% levobunolol and 0.1% dipivefrin
Number of subjects: 43
Study 3291837 — intervention group
Group type: COMPARATOR
Intervention: 0.5% timolol and 0.1% dipivefrin
Number of subjects: 43
Study 31931687 — intervention group
Group type: EXPERIMENTAL
Intervention: UCD MCQs (2010-2018)
Number of subjects: 200
Study 31931687 — intervention group
Group type: COMPARATOR
Intervention: UCD MCQs (2002-2009)
Number of subjects: 200
Study 31931687 — intervention group
Group type: COMPARATOR
Intervention: NBDE MCQs
Number of subjects: 200
Study 31931687 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of MCQs
Number of subjects: 200
Study 30169607 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0
Study 30169607 — intervention group
Group type: COMPARATOR
Intervention: Control (no dexamethasone)
Number of subjects: 0
Study 28583466 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls (≥1 falls after stroke)
Number of subjects: 250
Study 28583466 — intervention group
Group type: COMPARATOR
Intervention: No falls (control group)
Number of subjects: 250
Study 25183453 — intervention group
Group type: EXPERIMENTAL
Intervention: Beer (30 g alcohol/d, 660 mL)
Number of subjects: 33
Study 25183453 — intervention group
Group type: EXPERIMENTAL
Intervention: Non‐alcoholic beer (990 mL)
Number of subjects: 33
Study 25183453 — intervention group
Group type: EXPERIMENTAL
Intervention: Gin (30 g alcohol/d, 100 mL)
Number of subjects: 33
Study 23219367 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) to the left dorsolateral prefrontal cortex (dlPFC)
Number of subjects: 22
Study 23219367 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 22
Study 22021535 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI group (3-T MRI before biopsy)
Number of subjects: 85
Study 22021535 — intervention group
Group type: COMPARATOR
Intervention: Non-MRI group (no MRI before biopsy)
Number of subjects: 85
Study 18179676 — intervention group
Group type: EXPERIMENTAL
Intervention: pegaptanib
Number of subjects: 3
Study 18179676 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 3
Study 17201073 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal lengthening contractions (10 sets of 60 contractions at 10% maximum isometric strength, 1 min rest between sets)
Number of subjects: 10
Study 17201073 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal lengthening contractions (10 sets of 3 contractions at 100% maximum isometric strength, 3 min rest between sets)
Number of subjects: 10
Study 15352639 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 0
Study 15352639 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 0
Study 15352639 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0
Study 10687326 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical capsaicin
Number of subjects: 26
Study 10687326 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 26
Study 9342580 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (160 mg)
Number of subjects: 12
Study 9342580 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg)
Number of subjects: 12
Study 9342580 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (160 mg) + Atenolol (100 mg)
Number of subjects: 12
Study 8211873 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg)
Number of subjects: 8
Study 8211873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 3775691 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethamsylate
Number of subjects: 12
Study 3775691 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31867657 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage description
Number of subjects: 1353
Study 31867657 — intervention group
Group type: EXPERIMENTAL
Intervention: Concise language description
Number of subjects: 1353
Study 30010794 — intervention group
Group type: EXPERIMENTAL
Intervention: Soil-transmitted helminth (STH) infections (Ascaris, Trichuris, hookworm)
Number of subjects: 781
Study 27217455 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (Tam)
Number of subjects: 6144
Study 27217455 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (Let)
Number of subjects: 6144
Study 27217455 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen followed by Letrozole (Tam-Let)
Number of subjects: 6144
Study 27217455 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole followed by Tamoxifen (Let-Tam)
Number of subjects: 6144
Study 27217455 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen alone (Tam)
Number of subjects: 6144
Study 27217455 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole alone (Let)
Number of subjects: 6144
Study 24444418 — intervention group
Group type: EXPERIMENTAL
Intervention: New Nordic Diet (NND)
Number of subjects: 181
Study 24444418 — intervention group
Group type: COMPARATOR
Intervention: Average Danish Diet (ADD)
Number of subjects: 181
Study 24444418 — intervention group
Group type: EXPERIMENTAL
Intervention: Untargeted metabolomics approach
Number of subjects: 181
Study 23078492 — intervention group
Group type: EXPERIMENTAL
Intervention: Education, distribution, and fitting program
Number of subjects: 689
Study 20166409 — intervention group
Group type: COMPARATOR
Intervention: SRing: sectional matrix and separation ring (Garrison Dental)
Number of subjects: 105
Study 20166409 — intervention group
Group type: EXPERIMENTAL
Intervention: CRing: circumferential matrix (1101-c, KerrHawe SA) with separation ring
Number of subjects: 105
Study 20166409 — intervention group
Group type: EXPERIMENTAL
Intervention: CElliot: circumferential matrix and Elliot separator (PFINGST & Co)
Number of subjects: 105
Study 20166409 — intervention group
Group type: EXPERIMENTAL
Intervention: CWedge: circumferential matrix with a wedge only
Number of subjects: 105
Study 20166409 — intervention group
Group type: EXPERIMENTAL
Intervention: COptra: circumferential matrix and OptraContact (Vivadent)
Number of subjects: 105
Study 20166409 — intervention group
Group type: EXPERIMENTAL
Intervention: CCerana: circumferential matrix and a Cerana insert (Nordiska Dental)
Number of subjects: 105
Study 20166409 — intervention group
Group type: EXPERIMENTAL
Intervention: Walser: Walser matrix O-type (Dr Walser Dental GmbH)
Number of subjects: 105
Study 19060998 — intervention group
Group type: EXPERIMENTAL
Intervention: Global posture reeducation group (n=15) performing muscle chain stretching
Number of subjects: 33
Study 19060998 — intervention group
Group type: COMPARATOR
Intervention: Conventional stretching group (n=16) performing conventional static muscle stretching
Number of subjects: 33
Study 15723227 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg)
Number of subjects: 23
Study 15723227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 11908904 — intervention group
Group type: EXPERIMENTAL
Intervention: Oleic acid (OL)
Number of subjects: 50
Study 11908904 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate (CHO)
Number of subjects: 50
Study 11908904 — intervention group
Group type: EXPERIMENTAL
Intervention: Stearic acid (STE)
Number of subjects: 50
Study 11908904 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight saturated fatty acids (LMP)
Number of subjects: 50
Study 11908904 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans fatty acids + Stearic acid (TFA + STE)
Number of subjects: 50
Study 11908904 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans fatty acids (TFA)
Number of subjects: 50
Study 11908904 — intervention group
Group type: EXPERIMENTAL
Intervention: TFA/STE
Number of subjects: 50
Study 10477976 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan/NaF dentifrice (0.3% triclosan and 1100 ppm fluoride)
Number of subjects: 159
Study 10477976 — intervention group
Group type: COMPARATOR
Intervention: Control dentifrice (1100 ppm fluoride)
Number of subjects: 159
Study 8132906 — intervention group
Group type: EXPERIMENTAL
Intervention: Cues centered at 1 kHz (on-frequency)
Number of subjects: 0
Study 8132906 — intervention group
Group type: EXPERIMENTAL
Intervention: Cues centered at 900 Hz (off-frequency)
Number of subjects: 0
Study 8132906 — intervention group
Group type: EXPERIMENTAL
Intervention: Cues centered at 700 Hz (off-frequency)
Number of subjects: 0
Study 8132906 — intervention group
Group type: COMPARATOR
Intervention: No cues
Number of subjects: 0
Study 8132906 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency stimuli
Number of subjects: 0
Study 8132906 — intervention group
Group type: EXPERIMENTAL
Intervention: Roving the level of stimuli over a 40-dB range
Number of subjects: 0
Study 8132906 — intervention group
Group type: EXPERIMENTAL
Intervention: Masking waveform frozen within trials
Number of subjects: 0
Study 2674029 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg/per os/day)
Number of subjects: 20
Study 2674029 — intervention group
Group type: COMPARATOR
Intervention: Nitrazepam (5.0 mg/per os/day)
Number of subjects: 20
Study 4731336 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (10 to 60 mg, usually taken at night)
Number of subjects: 20
Study 4731336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30388905 — intervention group
Group type: EXPERIMENTAL
Intervention: Taekwondo training (TT)
Number of subjects: 20
Study 30388905 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 20
Study 28506387 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg daily
Number of subjects: 32
Study 28506387 — intervention group
Group type: COMPARATOR
Intervention: Control (no atorvastatin treatment)
Number of subjects: 32
Study 25559011 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System (DSS)
Number of subjects: 1628
Study 25559011 — intervention group
Group type: COMPARATOR
Intervention: Chart-Based Support (CBS)
Number of subjects: 1628
Study 23220855 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral paracetamol (Group OP)
Number of subjects: 130
Study 23220855 — intervention group
Group type: COMPARATOR
Intervention: Intravenous paracetamol (Group IP)
Number of subjects: 130
Study 21496253 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose tranexamic acid (TA) - loading dose 4 g over 1 hour, then infusion of 1 g/hour over 6 hours
Number of subjects: 144
Study 21496253 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose tranexamic acid (TA)
Number of subjects: 144
Study 21496253 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TA)
Number of subjects: 144
Study 18078985 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity counseling
Number of subjects: 624
Study 18078985 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 624
Study 16423029 — intervention group
Group type: EXPERIMENTAL
Intervention: Delton resin-based sealant
Number of subjects: 153
Study 16423029 — intervention group
Group type: COMPARATOR
Intervention: Fuji III glass-ionomer sealant
Number of subjects: 153
Study 15354382 — intervention group
Group type: EXPERIMENTAL
Intervention: Water rinse after formula consumption
Number of subjects: 0
Study 15354382 — intervention group
Group type: COMPARATOR
Intervention: Formula consumption without water rinse
Number of subjects: 0
Study 16144822 — intervention group
Group type: EXPERIMENTAL
Intervention: Preeclamptic women (PE)
Number of subjects: 38
Study 16144822 — intervention group
Group type: EXPERIMENTAL
Intervention: Preeclamptic women (PE) and healthy pregnant women (HP) pooled
Number of subjects: 38
Study 10501749 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (5 microg/kg per min)
Number of subjects: 24
Study 10501749 — intervention group
Group type: COMPARATOR
Intervention: Dopexamine (1 microg/kg per min)
Number of subjects: 24
Study 8723574 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa (300 to 600 IU/kg twice weekly for 3 weeks)
Number of subjects: 0
Study 8723574 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral iron saccharate supplementation
Number of subjects: 0
Study 8723574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1885422 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 0
Study 1885422 — intervention group
Group type: COMPARATOR
Intervention: In vitro data
Number of subjects: 0
Study 6888708 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (various doses)
Number of subjects: 0
Study 6888708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6888708 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine
Number of subjects: 0
Study 28893208 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous patisiran 0.3 mg/kg once every 3 weeks
Number of subjects: 0
Study 28893208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27692131 — intervention group
Group type: EXPERIMENTAL
Intervention: FF/VI 100/25 mcg
Number of subjects: 32
Study 27692131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 24170814 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM) at an initial dose of 1000 mg iron with subsequent dosing as necessary to target a serum ferritin level of 400-600 µg/L
Number of subjects: 626
Study 24170814 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM) at an initial dose of 200 mg with subsequent dosing as necessary to target serum ferritin 100-200 µg/L
Number of subjects: 626
Study 24170814 — intervention group
Group type: COMPARATOR
Intervention: Oral ferrous sulphate 200 mg iron/day
Number of subjects: 626
Study 21787450 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet (MedDiet) without weight loss
Number of subjects: 19
Study 21787450 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet (MedDiet) with weight loss
Number of subjects: 19
Study 21787450 — intervention group
Group type: COMPARATOR
Intervention: North American control diet
Number of subjects: 19
Study 19488608 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal calprotectin measurement
Number of subjects: 65
Study 19488608 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 outpatients with IBD)
Number of subjects: 65
Study 16850247 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel plus trastuzumab (4 mg/kg loading dose, then weekly 2 mg/kg)
Number of subjects: 124
Study 16850247 — intervention group
Group type: COMPARATOR
Intervention: Weekly paclitaxel alone (80 mg/m2)
Number of subjects: 124
Study 16850247 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel plus trastuzumab
Number of subjects: 124
Study 15165944 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade glutamate and aspartate (15 mmol/L) enriched cold crystalloid cardioplegia
Number of subjects: 34
Study 15165944 — intervention group
Group type: COMPARATOR
Intervention: Cold crystalloid cardioplegia by antegrade route
Number of subjects: 34
Study 12161089 — intervention group
Group type: EXPERIMENTAL
Intervention: Community intervention aimed at multiple cancer prevention health behaviors
Number of subjects: 20
Study 12161089 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline and follow-up surveys on intervention dose
Number of subjects: 20
Study 12161089 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveys conducted in three similar communities in another part of the state
Number of subjects: 20
Study 9612600 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrahepatic artery cisplatin
Number of subjects: 0
Study 9612600 — intervention group
Group type: COMPARATOR
Intervention: Intravenous doxorubicin and 5-FU
Number of subjects: 0